All SEC Filings :: Avalo Therapeutics, Inc. (AVTX)

Filing Type:

Year:

Date	Form	Description	Pages
04/09/24	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	5
04/05/24	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	8
04/03/24	3	Initial statement of beneficial ownership of securities Documents EX-24	2
04/03/24	3	Initial statement of beneficial ownership of securities Documents EX-24	2
04/03/24	3	Initial statement of beneficial ownership of securities Documents EX-24	2
03/29/24	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-3.2 EX-23.1 EX-31.1 EX-31.2 EX-32.1	144
03/29/24	8-K	Current report filing Documents EX-99.1	8
03/28/24	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	8
03/28/24	8-K	Current report filing Documents EX-2.1 EX-3.1 EX-3.2 EX-3.3 EX-4.1 EX-10.1 EX-10.2 EX-99.1 EX-99.2	229
02/14/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	8